QT
RXRX icon

Quantbot Technologies’s Recursion Pharmaceuticals RXRX Stock Holding History

Quantbot Technologies’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-18,846
Closed -$77.1K – 2098
2025
Q4 		$77.1K Buy
18,846
+6,402
+51% +$31.7K ﹤0.01% 1466
2025
Q3 		$60.7K Buy
+12,444
New +$65.4K ﹤0.01% 1501
2025
Q1 		– Sell
-403
Closed -$2.72K – 1821
2024
Q4 		$2.72K Buy
+403
New +$2.71K ﹤0.01% 1401
2024
Q2 		– Sell
-789
Closed -$7.87K – 1851
2024
Q1 		$7.87K Sell
789
-5,211
-87% -$58K ﹤0.01% 1467
2023
Q4 		$59.2K Buy
+6,000
New +$42.8K ﹤0.01% 1306

Other funds holding RXRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Quantbot Technologies's RXRX Position: Q1 2026 in Review

Quantbot Technologies sold out of Recursion Pharmaceuticals (RXRX) in Q1 2026, closing a stake of 18,846 shares — an estimated $77.1K sold.

Quantbot Technologies first reported a position in RXRX in Q4 2023 and held it in 5 quarters. The position peaked at $77.1K in Q4 2025. 334 funds tracked by Wall St. Rank hold RXRX as of Q1 2026.

  • Quantbot Technologies reported no remaining Recursion Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Quantbot Technologies sold 18,846 Recursion Pharmaceuticals shares in Q1 2026, an estimated $77.1K.
  • Quantbot Technologies first reported a position in Recursion Pharmaceuticals in Q4 2023 and held it in 5 quarters.
  • Quantbot Technologies's Recursion Pharmaceuticals position peaked at $77.1K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q1 2026.

Based on Quantbot Technologies's 13F filing for Q1 2026, filed 13 May 2026.